Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, announced that its management team will participate in two investor conferences.

iAccess Alpha Virtual Best Ideas Winter Conference 2024

Date: December 10-11, 2024

Location: Virtual

Presentation: December 10, 2024, at 10:00 am ET

Webcast:

CEO Danny Yeung will present on December 10, 2024, with CFO Stephen Lo and President of Prenetics Americas David Vanderveen available for individual meetings on December 11, 2024.

13th Annual ROTH Deer Valley Event

Date: December 11-13, 2024

Location: Park City, UT

David Vanderveen, President of Prenetics Americas, will conduct individual investor meetings throughout the conference.

Mr. Vanderveen brings a 30-year successful background in beverages, nutrition, and technology, having driven innovation at Nirvana Water Sciences and XS Worldwide as CEO.

For scheduling meetings, contact Prenetics investor relations at .

About Prenetics

Prenetics (NASDAQ:PRE), a leading health sciences company, focuses on advancing consumer and clinical health. Its consumer initiatives include IM8, a new health and wellness brand, and Europa, a major US sports distributor. The clinical division features Insighta, a $200 million venture focused on multi-cancer early detection; ACT Genomics, with FDA clearance for comprehensive genomic profiling of solid tumors; and CircleDNA, offering comprehensive DNA tests using NGS. Prenetics’ units work together to improve global health, reflecting its commitment to ‘enhancing life through science’. For more information, visit .

Investor Relations Contact:

Angela Cheung
Investor Relations / Corporate Finance
Prenetics Global Limited